INNOCENTI METELLO ENZO

Barbieri, L., Salvioni, L., Banfi, A., Garbujo, S., Fiandra, L., Baioni, C., et al. (2025). Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer. ACS APPLIED MATERIALS & INTERFACES [10.1021/acsami.5c06626]. Detail

Perciballi, E., Bovio, F., Ferro, S., Forcella, M., Rosati, J., Carletti, R., et al. (2025). Mitochondrial and energy metabolism dysfunctions are hallmarks of TDP-43G376D fibroblasts from members of an Amyotrophic Lateral Sclerosis family. CELL DEATH & DISEASE, 16(1) [10.1038/s41419-025-07584-2]. Detail

di Miceli, N., Baioni, C., Barbieri, L., Danielli, D., Sala, E., Salvioni, L., et al. (2024). TGF-β Signaling Loop in Pancreatic Ductal Adenocarcinoma Activates Fibroblasts and Increases Tumor Cell Aggressiveness. CANCERS, 16(21) [10.3390/cancers16213705]. Detail

Baioni, C., Innocenti, M., Colombo, M., Prosperi, D. (2024). Killing cancer cells by targeting the tumor microenvironment: study of TRAIL journey in a CAFs model. Intervento presentato a: BtBsDay 2024, Milano, Italia. Detail

Galli, M., Marongiu, L., Cozzi, S., Rocca, G., Stucchi, G., Celant, A., et al. (2024). Calcineurin blockade modifies dendritic cell differentiation and induces a tolerogenic phenotype. Intervento presentato a: European Conference of Immunology, Dublino, Irlanda [10.1002/eji.202470200]. Detail